Somanetics Corporation (NASDAQ: SMTS) focuses on developing, manufacturing and marketing the INVOS® Cerebral/Somatic Oximeter. This non-invasive patient monitoring system constantly measures changes in the blood oxygen levels in patients with or at risk for restricted blood flow. The INVOS System also provides the information necessary to identify oxygen imbalances in tissues beneath the sensor, allowing medical professionals to take corrective action. For further information, visit the Company’s web site at www.somanetics.com.
- 17 years ago
QualityStocks
Somanetics Corporation (NASDAQ: SMTS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Launches 12-Month AI-Driven Marketing Campaign With AGORACOM
LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced a 12-month online marketing campaign with…
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Strengthens Balance Sheet with Full Conversion of $13.3 Million Notes
Datavault AI (NASDAQ: DVLT), a pioneer in AI-driven data monetization, announced the full conversion of…
-
Nightfood Holdings Inc. (NGTF) Offering a Portfolio of AI-Powered Robots Designed to Streamline Operations and Enhance Efficiency
Nightfood Holdings has a lineup of AI-powered robots to streamline operations across industries, weaving technology…